Integrity Alliance’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$757K Buy
5,080
+445
+10% +$62.4K 0.02% 448
2026
Q2
$586K Buy
4,635
+716
+18% +$94.3K 0.02% 469
2026
Q1
$546K Sell
3,919
-176
-4% -$24.6K 0.02% 421
2025
Q4
$503K Buy
+4,095
New +$498K 0.02% 460
2025
Q2
– Sell
-1,872
Closed -$210K – 550
2025
Q1
$210K Buy
+1,872
New +$193K 0.01% 579

Other funds holding GILD

Integrity Alliance's GILD Position: Q3 2026 in Review

Integrity Alliance increased its Gilead Sciences (GILD) stake by 9.6% in Q3 2026, buying an estimated $62.4K and bringing the position to 5,080 shares worth $757K. The position accounts for 0.02% of the portfolio, ranked #448.

Integrity Alliance first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. 1,474 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Integrity Alliance held 5,080 shares of Gilead Sciences worth $757K as of Q3 2026.
  • Integrity Alliance bought 445 Gilead Sciences shares in Q3 2026, an estimated $62.4K.
  • Gilead Sciences made up 0.02% of Integrity Alliance's portfolio in Q3 2026, its #448 holding.
  • Integrity Alliance first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • 1,474 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Integrity Alliance's 13F filing for Q3 2026, filed 29 Oct 2026.